Fate Therapeutics

In News

Single-dose lupus therapy shows responses without conditioning chemo - Stock Titan

Stock Titan - May 11, 2026

Fate Therapeutics presents CAR T-cell therapy data at ASGCT By Investing.com - Investing.com Canada

Investing.com Canada - May 11, 2026

Number of shareholders of Fate Therapeutics, Inc. – NASDAQ:FATE - TradingView

TradingView - May 09, 2026

Fate Therapeutics (FATE) Eps Diluted (TTM) - Zacks Investment Research

Zacks Investment Research - May 09, 2026

Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819 - Yahoo Finance

Yahoo Finance - May 05, 2026

Fate Therapeutics (FATE) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

MarketBeat - May 05, 2026

MSN Money - MSN

MSN - May 09, 2026

Fate Therapeutics (FATE) officer exercises 166,664 options, holds 609k shares - Stock Titan

Stock Titan - May 07, 2026

Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - Yahoo Finance

Yahoo Finance - Feb 26, 2026

Fate Therapeutics Announces Three Presentations at the 2026 - GlobeNewswire

GlobeNewswire - May 04, 2026

Fate Therapeutics Selected For U.S. FDA Chemistry, Manufacturing, And Controls Development And Readiness Pilot Program To Support Manufacturing Readiness Of Ft819 - TradingView

TradingView - May 05, 2026

Director at Fate Therapeutics (NASDAQ: FATE) exercises 25,000 stock options - Stock Titan

Stock Titan - May 06, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment